These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 32458510)
21. Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia. Ozbagcivan O; Akarsu S; Nazli EC; Lebe B; Fetil E Ann Hematol; 2021 Jan; 100(1):293-294. PubMed ID: 32221651 [No Abstract] [Full Text] [Related]
23. Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review. Fanci R; Pini G; Bartolesi AM; Pecile P Rev Iberoam Micol; 2013 Jan; 30(1):51-3. PubMed ID: 22659590 [TBL] [Abstract][Full Text] [Related]
24. [State of the art in invasive diseases by filamentous fungi]. Pemán J; Quindós G Rev Iberoam Micol; 2014; 31(4):213-8. PubMed ID: 25449676 [TBL] [Abstract][Full Text] [Related]
25. Ibrutinib-associated necrotic nasal lesion and pulmonary infiltrates. Saling C; Feller F; Vikram HR BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33468501 [TBL] [Abstract][Full Text] [Related]
26. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Marr KA; Carter RA; Crippa F; Wald A; Corey L Clin Infect Dis; 2002 Apr; 34(7):909-17. PubMed ID: 11880955 [TBL] [Abstract][Full Text] [Related]
27. Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections. Maffei R; Maccaferri M; Arletti L; Fiorcari S; Benatti S; Potenza L; Luppi M; Marasca R Blood Rev; 2020 Mar; 40():100635. PubMed ID: 31699465 [TBL] [Abstract][Full Text] [Related]
28. Molecular epidemiology of clinical filamentous fungi in Qatar beyond Aspergillus and Fusarium with notes on the rare species. Salah H; Houbraken J; Boekhout T; Almaslamani M; Taj-Aldeen SJ Med Mycol; 2022 Dec; 61(1):. PubMed ID: 36592959 [TBL] [Abstract][Full Text] [Related]
29. A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre-ibrutinib era. Steingrímsson V; Gíslason GK; Þorsteinsdóttir S; Rögnvaldsson S; Gottfreðsson M; Aspelund T; Turesson I; Björkholm M; Landgren O; Kristinsson SY Eur J Haematol; 2021 Mar; 106(3):346-353. PubMed ID: 33211356 [TBL] [Abstract][Full Text] [Related]
30. Ibrutinib induces multiple functional defects in the neutrophil response against Blez D; Blaize M; Soussain C; Boissonnas A; Meghraoui-Kheddar A; Menezes N; Portalier A; Combadière C; Leblond V; Ghez D; Fekkar A Haematologica; 2020; 105(2):478-489. PubMed ID: 31171644 [TBL] [Abstract][Full Text] [Related]
31. Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis. Brochard J; Morio F; Mahe J; Le Pape P; Guimard T; Mahe B; Leterrier M; Morrier M; Raffi F; Boutoille D Med Mal Infect; 2020 Nov; 50(8):742-745. PubMed ID: 32777360 [TBL] [Abstract][Full Text] [Related]
32. Emerging moulds: epidemiological trends and antifungal resistance. Miceli MH; Lee SA Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045 [TBL] [Abstract][Full Text] [Related]
33. Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study. Gentile M; Morabito F; Del Poeta G; Mauro FR; Reda G; Sportoletti P; Laurenti L; Coscia M; Herishanu Y; Recchia AG; Varettoni M; Murru R; Chiarenza A; Condoluci A; Moia R; Pietrasanta D; Loseto G; Consoli U; Scortechini I; Rossi FM; Zucchetto A; Fraticelli V; Vigna E; Botta C; Tripepi G; Arrigo G; Rago A; Angeletti I; Biagi A; Del Giudice I; Bomben R; Rigolin GM; Rossi D; Di Raimondo F; Gaidano G; Polliack A; Cuneo A; Foà R; Gattei V Leukemia; 2021 Jan; 35(1):235-238. PubMed ID: 32286543 [No Abstract] [Full Text] [Related]
34. Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature. Ricna D; Lengerova M; Palackova M; Hadrabova M; Kocmanova I; Weinbergerova B; Pavlovsky Z; Volfova P; Bouchnerova J; Mayer J; Racil Z Mycoses; 2016 Jan; 59(1):48-55. PubMed ID: 26661324 [TBL] [Abstract][Full Text] [Related]